AlphaRx Inc. Logo
AlphaRx Announces Completion of Phase II Clinical Trial for Indaflex
March 05, 2007 08:00 ET | AlphaRx Inc.
MARKHAM, Ontario, March 5, 2007 (PRIME NEWSWIRE) -- AlphaRx (OTCBB:ALRX) announced today the completion of the treatment phase of the double-blind, placebo & vehicle-controlled, randomized and...
AlphaRx Inc. Logo
AlphaRx's Nanoparticle Formulation of Antituberculosis Drug Shows Promise in Mice Infected With TB (Mycobacterium Tuberculosis)
February 20, 2007 08:00 ET | AlphaRx Inc.
A leading Chinese TB research institute evaluated the efficacy of the Company's nanoparticle-encapsulated Streptomycin administered 2 times a week versus that of daily nonencapsulated drug...
AlphaRx Inc. Logo
AlphaRx Provides Positive Update On Indaflex
January 09, 2007 10:45 ET | AlphaRx Inc.
MARKHAM, Ontario, Jan. 9, 2007 (PRIME NEWSWIRE) -- AlphaRx Inc. (OTCBB:ALRX) is pleased to announce that Proprius Pharmaceuticals Inc. has raised up to $17M in a Series A financing. A large portion of...
AlphaRx Inc. Logo
AlphaRx's Joint Venture Company Receives Marketing Approval for Flexogan in Hong Kong
March 08, 2006 08:00 ET | AlphaRx Inc.
MARKHAM, Ontario, March 8, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
AlphaRx Inc. Logo
AlphaRx Receives Notice of Allowance for U.S. Patent on Its Drug Delivery Platform
January 25, 2006 08:00 ET | AlphaRx Inc.
MARKHAM, Ontario, Jan. 25, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
AlphaRx Inc. Logo
AlphaRx Updates Binoxan Development, a Potential Non-Irritating, Twice-a-Day Eye Drop for Ocular Inflammation
January 17, 2006 08:00 ET | AlphaRx Inc.
MARKHAM, Ontario, Jan. 17, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
AlphaRx Inc. Logo
AlphaRx's Joint Venture Company Receives Marketing Approval for Flexogan Ultra in Hong Kong
January 10, 2006 08:00 ET | AlphaRx Inc.
MARKHAM, Ontario, Jan. 10, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
AlphaRx Inc. Logo
AlphaRx Launches Flexogan's First National TV Campaign with World Wrestling Entertainment
April 01, 2004 08:30 ET | AlphaRx Inc.
RICHMOND HILL, Ontario, Canada, April 1, 2004 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX) is launching its first Canadian national TV campaign with World Wrestling Entertainment Canada, Inc. to support...